Suncheng Xiang | Machine Learning and AI Applications | Best Researcher Award

Assist Prof Dr. Suncheng Xiang | Machine Learning and AI Applications | Best Researcher Award

Shanghai Jiao Tong University | China

PUBLICATION PROFILE

Google Scholar

🎓 EARLY ACADEMIC PURSUITS

Dr. Suncheng Xiang’s academic journey began with a B.S. in Electrical Engineering and Automation from Changsha University of Science & Technology (2010–2014), where he demonstrated early promise through multiple scholarships and honors. He pursued an M.S. in Software Engineering at the National University of Defense Technology (NUDT) from 2014 to 2017, continuing his academic excellence with multiple recognitions, including first-class scholarships and “Outstanding Student” awards. His scholarly momentum led to a Ph.D. in Computer Science and Technology at Shanghai Jiao Tong University (SJTU) from 2017 to 2022, where he laid the foundation for his work at the intersection of artificial intelligence and medical technology.

💼 PROFESSIONAL ENDEAVORS

Currently serving as an Assistant Professor at the School of Biomedical Engineering, SJTU, since August 2022, Dr. Xiang is also co-affiliated with the Institute of Medical Robotics, reflecting his interdisciplinary engagement. His teaching portfolio includes courses like Artificial Intelligence and Medicine and Medical Imaging Intelligence Technology, and he has served as a lead TA in core computing courses during his academic years. His professional memberships with IEEE and ACM further demonstrate his integration into the global scientific community.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Xiang’s research lies at the convergence of machine learning, computer vision, and biomedical applications, with significant work in domain adaptation, image generation, 3D reconstruction, and multimodal foundation models. He has contributed to both theoretical advancements and real-world solutions, evident in his published preprints on arXiv, which explore topics such as polyp re-identification, medical image segmentation, and gesture recognition. His innovation extends to patents—notably in vessel re-identification using transfer learning and a reusable implantable drive mechanism.

🌍 IMPACT AND INFLUENCE

As an active reviewer for more than 40 peer-reviewed journals—including prestigious outlets like IEEE Transactions on Medical Imaging, Pattern Recognition, and Machine Learning—Dr. Xiang holds a Distinguished Reviewer title. He is also an associate editor for several journals such as Biomedical Engineering Communications and Intelligent Manufacturing. His presence at major conferences like CVPR, ICCV, MICCAI, and EMNLP as a reviewer, session chair, or workshop organizer highlights his growing influence in global academic discourse. Additionally, his invited talks at leading institutions such as Fudan University, Wuhan University, and international platforms demonstrate his thought leadership.

📈 ACADEMIC CITES

Dr. Xiang’s open-source philosophy and dedication to knowledge sharing are reflected in his active GitHub repository, where he shares code and models related to his publications. This contributes to his growing academic citations and impact, as his works are used by fellow researchers and practitioners alike. Although specific citation metrics aren’t listed, his consistent involvement in high-profile research and collaboration across multidisciplinary teams suggests a rising citation trajectory.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Dr. Xiang’s leadership in multimodal cognitive learning, AI for healthcare, and robotic surgery is poised to contribute significantly to next-generation biomedical systems. His ongoing national and municipal-level projects, including the National Natural Science Foundation of China Youth Project and Shanghai Municipal Health Commission projects, indicate sustained support and expectations from the research community. With a rich portfolio in teaching, mentorship, and interdisciplinary collaboration, Dr. Xiang is building a legacy that bridges technical innovation with clinical translation.

 📚 TOP NOTES PUBLICATIONS

Vm-unet: Vision mamba unet for medical image segmentation
    • Authors: J. Ruan, J. Li, S. Xiang

    • Journal/Conference: arXiv preprint arXiv:2402.02491

    • Year: 2024

Malunet: A multi-attention and light-weight unet for skin lesion segmentation
    • Authors: J. Ruan, S. Xiang, M. Xie, T. Liu, Y. Fu

    • Journal/Conference: 2022 IEEE International Conference on Bioinformatics and Biomedicine (BIBM)

    • Year: 2022

Unsupervised domain adaptation through synthesis for person re-identification
    • Authors: S. Xiang, Y. Fu, G. You, T. Liu

    • Journal/Conference: 2020 IEEE International Conference on Multimedia and Expo (ICME)

    • Year: 2020

Less is more: Learning from synthetic data with fine-grained attributes for person re-identification
    • Authors: S. Xiang, D. Qian, M. Guan, B. Yan, T. Liu, Y. Fu, G. You

    • Journal/Conference: ACM Transactions on Multimedia Computing, Communications and Applications

    • Year: 2023

Learning from self-discrepancy via multiple co-teaching for cross-domain person re-identification
    • Authors: S. Xiang, Y. Fu, M. Guan, T. Liu

    • Journal/Conference: Machine Learning

    • Year: 2023

Rethinking illumination for person re-identification: A unified view
    • Authors: S. Xiang, G. You, L. Li, M. Guan, T. Liu, D. Qian, Y. Fu

    • Journal/Conference: Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR)

    • Year: 2022

Isabel Lastres-Becker | Emerging Research Trends | Best Researcher Award

Dr. Isabel Lastres-Becker | Emerging Research Trends | Best Researcher Award

Universidad Autónoma de Madrid | Spain

PUBLICATION PROFILE

Scopus

Orcid

INTRODUCTION 👩‍🔬

Dr. Isabel Lastres-Becker is an Associate Professor at the Universidad Autónoma de Madrid, specializing in biochemistry and neurodegenerative diseases. With over 20 years of research experience, her scientific work primarily focuses on the molecular mechanisms of neurodegeneration, including oxidative stress, neuroinflammation, and proteinopathies. Her contributions span several neurodegenerative disorders, including Parkinson’s disease, Alzheimer’s, ALS, and Huntington’s disease.

EARLY ACADEMIC PURSUITS 🎓

Dr. Lastres-Becker completed her Licenciatura en Ciencias Químicas (Bachelor’s degree in Chemistry) with a specialization in Biochemistry from Universidad Complutense de Madrid in 1997. She later earned her PhD in Biochemistry in 2003 from the same institution, with a focus on neurodegenerative diseases. Her doctoral research was awarded the prestigious European mention.

PROFESSIONAL ENDEAVORS 👩‍🏫

Throughout her career, Dr. Lastres-Becker has held various academic and research positions. She is currently an Associate Professor at the Universidad Autónoma de Madrid since October 2021, after having previously served as a Ramón y Cajal researcher and Postdoctoral Researcher in Spain and Germany. Her experience in both the academic and research environments has greatly contributed to her expertise in neurodegenerative diseases.

CONTRIBUTIONS AND RESEARCH FOCUS 🔬

Dr. Lastres-Becker’s research contributions have had a significant impact on the understanding of neurodegenerative diseases. Her work has focused on various aspects:

  • Cannabinoid System in Huntington’s Disease: Dr. Lastres-Becker explored how the dysregulation of the endogenous cannabinoid system affects Huntington’s disease. Her work laid the groundwork for clinical trials examining the neuroprotective effects of cannabinoids.
  • Parkinson’s Disease: She demonstrated how cannabinoid receptors, particularly CB1, are involved in neuroinflammation in Parkinson’s disease, and her research suggested potential therapeutic targets for modulating microglial activity.
  • Ataxin-2 in Spinocerebellar Ataxia: She was the first to identify the role of ataxin-2 in metabolism and protein synthesis, as well as its involvement in SCA2 neurodegeneration.
  • NRF2 Transcription Factor: Dr. Lastres-Becker’s research on NRF2 has revealed its central role in neurodegenerative diseases. She showed how NRF2’s involvement in inflammatory processes could be a therapeutic target, particularly in the context of Parkinson’s disease and tauopathies.
  • Neuron-Glia Communication: In Alzheimer’s disease, Dr. Lastres-Becker identified how neurons with overexpressed TAU protein release fractalkine (CX3CL1), triggering neuroinflammation and tau-related neurodegeneration.

IMPACT AND INFLUENCE 🌍

Dr. Lastres-Becker’s research is not only impactful within the academic sphere but also in the broader scientific and clinical communities. She serves as an external collaborator with several research groups and is a reviewer for high-impact scientific journals. Additionally, her collaborations with international research agencies and companies have advanced the therapeutic exploration of neurodegenerative diseases.

ACADEMIC CITATIONS AND PUBLICATIONS 📚

Dr. Lastres-Becker has authored more than 65 publications, contributing significantly to neurodegenerative disease research. Some of her high-impact publications include studies on the cannabinoid system, NRF2 modulation, and tauopathies, with her work frequently cited in the fields of neurobiology and pharmacology. These studies have not only contributed to scientific knowledge but have also provided the foundation for potential clinical therapies.

HONORS & AWARDS 🏆

Throughout her career, Dr. Lastres-Becker has received numerous awards and grants, including funding from the Spanish Ministry of Science and Innovation. Her work has been recognized through various prestigious research projects aimed at studying and developing therapeutics for Parkinson’s disease, ALS, and Alzheimer’s disease.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

Looking ahead, Dr. Lastres-Becker continues to contribute to the advancement of therapeutic strategies for neurodegenerative diseases. She is currently involved in various cutting-edge research projects focused on the roles of NRF2, cannabinoids, and proteostasis. Her future work aims to bridge the gap between preclinical discoveries and clinical applications, ultimately improving treatment outcomes for patients with these devastating conditions.

TOP NOTES PUBLICATIONS 📚

Model organisms for investigating the functional involvement of NRF2 in non-communicable diseases
    • Authors: A.I. Rojo, B. Buttari, S. Cadenas, I.P. Trougakos, A.T. Dinkova-Kostova
    • Journal: Redox Biology
    • Year: 2025
Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy
    • Authors: S. Burgaz, E. Navarro, S. Rodríguez-Carreiro, E.E. Muñóz, J.J. Fernández-Ruiz
    • Journal: Behavioral and Brain Functions
    • Year: 2024
Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia
    • Authors: I. Silva-Llanes, R. Martín-Baquero, A. Berrojo-Armisen, E. De Lago, I. Lastres-Becker
    • Journal: Antioxidants
    • Year: 2024
Biomarkers of NRF2 signalling: Current status and future challenges
    • Authors: C. Morgenstern, I. Lastres-Becker, B.C. Demirdogen, A. Cuadrado, I.M. Copple
    • Journal: Redox Biology
    • Year: 2024
RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection
    • Authors: I. Silva-Llanes, E. Madruga, A.R. Martínez, I. Lastres-Becker
    • Journal: Frontiers in Neuroscience
    • Year: 2024